Advertisement
| idsa abstract submission: Emerging Infectious Diseases , 1999 |
| idsa abstract submission: Innovation , 1997 One issue each year consists of an annual conference review. |
| idsa abstract submission: HIV Infection in Children and Adolescents Raziya Bobat, 2020-02-27 This book serves as a reference work on pediatric HIV infection and covers the full bandwidth of topics from an introduction to pathogenesis and epidemiology, over the transmission of the HI virus, to clinical manifestations, treatment, and prevention strategies. Diseases and disorders occurring in HIV infected persons are discussed in detail. The book covers special populations, such as neonates born to an HIV positive mother and adolescents and examines the specific ways of managing HIV disease in these patient groups. This is the first book to cover palliative care as well as ethical, legal and social issues of HIV infection. |
| idsa abstract submission: Management of Acute Pulmonary Embolism Stavros V. Konstantinides, 2010-11-09 This practical volume highlights traditional, novel, and evolving aspects of the diagnosis and treatment of pulmonary embolism (PE). The contributors comprise an international team of experts. Important aspects of diagnosis, risk stratification, and differential treatment of patients with PE are presented in a concise, yet comprehensive manner. Emphasis is placed on specific issues related to PE, including pregnancy, cancer, thrombophilia, and air travel. |
| idsa abstract submission: Catheter-Related Infections Dr. Harald Seifert, Bernd Jansen, Barry M. Farr, 1997-05-06 This timely guide details, in a highly accessible manner, the pathogenesis, epidemiology, and major complications of catheter-related infections (CRIs) as well as the types of catheters and etiological agents involved-providing practical approaches to the diagnosis, management, and prevention of CRIs. |
| idsa abstract submission: Severe Community Acquired Pneumonia Jordi Rello, Kenneth V. Leeper, Kenneth Leeper, 2001-06-30 Severe Community Acquired Pneumonia is a book in which chapters are authored and the same topics discussed by North American and European experts. This approach provides a unique opportunity to view the different perspectives and points of view on this subject. Severe CAP is a common clinical problem encountered in the ICU setting. This book reviews topics concerning the pathogenesis, diagnosis and management of SCAP. The discussions on the role of alcohol in severe CAP and adjunctive therapies are important topics that further our understanding of this severe respiratory infection. |
| idsa abstract submission: Pediatric Hepatology William F. Balistreri, J. Thomas Stocker, 1990-04-01 Third in a series of textbooks on pediatric disease primarily based on annual seminars held at the Gant in Aspen, Colorado as part of the Aspen conference on Pediatric Diseases, directed by the Institute for Pediatric Medical Education founded in 1981. |
| idsa abstract submission: Medical Microbiology and Infection Tom Elliott, Anna Casey, Peter A. Lambert, Jonathan Sandoe, 2011-11-14 Medical Microbiology and Infection Lecture Notes is ideal for medical students, junior doctors, pharmacy students, junior pharmacists, nurses, and those training in the allied health professions. It presents a thorough introduction and overview of this core subject area, and has been fully revised and updated to include: Chapters written by leading experts reflecting current research and teaching practice New chapters covering Diagnosis of Infections and Epidemiology and Prevention & Management of Infections Integrated full-colour illustrations and clinical images A self-assessment section to test understanding Whether you need to develop your knowledge for clinical practice, or refresh that knowledge in the run up to examinations, Medical Microbiology and Infection Lecture Notes will help foster a systematic approach to the clinical situation for all medical students and hospital doctors. |
| idsa abstract submission: ASM news , 1963 |
| idsa abstract submission: TB Notes , 2000 |
| idsa abstract submission: Growing Physician Leaders Mark Hertling, 2016 Physicians hold the key to improving healthcare, but few doctors get trained in the leadership necessary to turn it. Gen. Mark Hertling applies his four decades of military leadership to the world of healthcare, resulting in profoundly constructive training that can help doctors reshape and reenergize any healthcare organization in America today. |
| idsa abstract submission: Periprosthetic Joint Infection: Practical Management Guide Parvizi Javad , Kerr Glenn J, Glynn Aaron, Higuera Carlos A, Hansen Erik N, 2013-12-15 This book Periprosthetic Joint Infection is a portable guide to the practical management of surgical site infections following orthopedic procedures. It designed to help answer clinician's questions regarding the prevention and treatment of periprosthetic infections. It organized for rapid review, featuring evidence reviews, pitfalls, Rothman Institute Current Practices and Controversies. The guide is being included in the course materials for the 29th Annual Current Concepts in Joint Replacement® (CCJR) meeting thanks to a generous educational grant from 3M Health Care. |
| idsa abstract submission: Prosthetic Joint Infections Trisha Peel, 2017-11-28 This book outlines the most updated clinical guidelines that are vital for the prevention infections and care of patients with joint infections following a replacement surgery, one of the highest volume medical interventions globally. Sections address the diagnosis, management approaches and prevention of prosthetic joint infections. Written by experts in the field, this text provides a brief overview of the literature and current recommendations in each of the specified areas. Given the rapidly evolving state-of-play in this clinical area, this compendium grows increasingly important to clinicians in their management decisions. Prosthetic Joint Infections is a valuable resource for infectious disease specialists, epidemiologists, surgeons, and orthopedic specialists who may work with patients with prosthetic joint infections. |
| idsa abstract submission: WHO Guidelines on Hand Hygiene in Health Care World Health Organization, 2009 The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to improve practices and reduce transmission of pathogenic microorganisms to patients and HCWs. The present Guidelines are intended to be implemented in any situation in which health care is delivered either to a patient or to a specific group in a population. Therefore, this concept applies to all settings where health care is permanently or occasionally performed, such as home care by birth attendants. Definitions of health-care settings are proposed in Appendix 1. These Guidelines and the associated WHO Multimodal Hand Hygiene Improvement Strategy and an Implementation Toolkit (http://www.who.int/gpsc/en/) are designed to offer health-care facilities in Member States a conceptual framework and practical tools for the application of recommendations in practice at the bedside. While ensuring consistency with the Guidelines recommendations, individual adaptation according to local regulations, settings, needs, and resources is desirable. This extensive review includes in one document sufficient technical information to support training materials and help plan implementation strategies. The document comprises six parts. |
| idsa abstract submission: List of Journals Indexed for MEDLINE , 2005 |
| idsa abstract submission: Guideline for Isolation Precautions in Hospitals Julia S. Garner, 1983 |
| idsa abstract submission: Rickettsial Diseases Didier Raoult, Philippe Parola, 2007-04-26 The only available reference to comprehensively discuss the common and unusual types of rickettsiosis in over twenty years, this book will offer the reader a full review on the bacteriology, transmission, and pathophysiology of these conditions. Written from experts in the field from Europe, USA, Africa, and Asia, specialists analyze specific patho |
| idsa abstract submission: Antifungal Therapy Mahmoud Ghannoum, John R. Perfect, 2016-04-19 A concise one-stop-practical reference for the various physicians dealing with fungal infections, Antifungal Therapy appeals to infectious disease physicians, transplant surgeons, dermatologists, and intensivists, as well as basic scientists and pharmaceutical company researchers interested in the state of antifungal therapy. This book provides a c |
| idsa abstract submission: Emerging Bacterial Pathogens I. Mühldorfer, K. P. Schäfer, A. Schmidt, H. Herwald, 2001-07 One of the greatest public health achievements during the last century was the reduction of infectious diseases due to public sanitation measures, vaccines and antibiotics. However, in recent years, several new infectious diseases have been identified, and since the appearance of the first penicillin-resistant bacteria, ‘old diseases’ have reemerged. Volume 8 of Contributions to Microbiology provides an overview of a great variety of bacterial pathogens representative of those groups and discusses the underlying reasons for disease emergence. The various chapters clearly illustrate how changes in society, technology and the environment result in the appearance or spread of bacterial pathogens. Not only bacterial human pathogens, but also bacterial plant pathogens are an issue and serve as an example of how bacteria can adapt very specifically to a particular host environment. As a consequence of this adaptability, the available antimicrobial drugs have become less effective against many infectious agents; the reasons for this are thoroughly discussed in the book. There is an urgent need for the development of new antibiotics. The volume therefore concludes with a chapter on modern approaches which allow a rational design of a new generation of antimicrobial drugs less likely to become ineffective or cause broad-spectrum drug resistance. Emerging Bacterial Pathogens is a valuable resource primarily for scientific and medical professionals as well as for students working in the field of infectious diseases, but will also be of interest to health officials and to the general public interested in public health issues. |
| idsa abstract submission: Bulletin of the World Health Organization World Health Organization, 2006 |
| idsa abstract submission: Mastering Community Christine Porath, 2022-03-08 From the author of Mastering Civility, a thoroughly researched exploration of the impact and importance of building thriving communities, with actionable steps on how to create them in your work and broader life. In her powerful new book, Christine Porath explores how the rise of technology and modern workplace practices have fractured our communications yet left us always “on” digitally. Through now common practices like hot-desking and remote work (even without the added isolation of social distancing we experienced during the pandemic), our human interactions have decreased, and so too have our happiness levels. This lack of a “human factor” is sparking a crisis in mental health that will have repercussions for years to come, leaving people lonelier and making the bottom line suffer, too. What Christine has discovered in her research is that leaders, organizations, and managers of all stripes may recognize there is a cost, but have no idea as to implement the cure: Community. With her signature depth and grasp of research across myriad industries including business, healthcare, hospitality, and sports, Christine extrapolates from the statistics on the experiences of hundreds of thousands of people across six continents to show us the potential for change. Through sharing information about the community, empowering decision-making discretion and autonomy, creating a respectful environment, offering feedback, providing a sense of meaning, and boosting member well-being, anyone can help a community truly flourish. The applications are endless, the stories are positive and uplifting, and will inspire the reader to establish and grow their community—be it in the workplace or the PTA—and make it thrive. |
| idsa abstract submission: Mismatch Kat Holmes, 2018-10-16 How inclusive methods can build elegant design solutions that work for all. Sometimes designed objects reject their users: a computer mouse that doesn't work for left-handed people, for example, or a touchscreen payment system that only works for people who read English phrases, have 20/20 vision, and use a credit card. Something as simple as color choices can render a product unusable for millions. These mismatches are the building blocks of exclusion. In Mismatch, Kat Holmes describes how design can lead to exclusion, and how design can also remedy exclusion. Inclusive design methods—designing objects with rather than for excluded users—can create elegant solutions that work well and benefit all. Holmes tells stories of pioneers of inclusive design, many of whom were drawn to work on inclusion because of their own experiences of exclusion. A gamer and designer who depends on voice recognition shows Holmes his “Wall of Exclusion,” which displays dozens of game controllers that require two hands to operate; an architect shares her firsthand knowledge of how design can fail communities, gleaned from growing up in Detroit's housing projects; an astronomer who began to lose her eyesight adapts a technique called “sonification” so she can “listen” to the stars. Designing for inclusion is not a feel-good sideline. Holmes shows how inclusion can be a source of innovation and growth, especially for digital technologies. It can be a catalyst for creativity and a boost for the bottom line as a customer base expands. And each time we remedy a mismatched interaction, we create an opportunity for more people to contribute to society in meaningful ways. |
| idsa abstract submission: Public Health Mycobacteriology Patricia T. Kent, 1985 |
| idsa abstract submission: Morbidity and Mortality Weekly Report , 2001 |
| idsa abstract submission: Guidelines on the Management of Latent Tuberculosis Infection WHO, World Health Organization, 2015-01-15 BACKGROUND: Latent tuberculosis infection (LTBI), defined as a state of persistent immune response to prior-acquired Mycobacterium tuberculosis antigens without evidence of clinically manifested active TB, affects about one-third of the world's population. Approximately 10% of people with LTBI will develop active TB disease in their lifetime, with the majority developing it within the first five years after initial infection. Currently available treatments have an efficacy ranging from 60% to 90%. Systematic testing and treatment of LTBI in at-risk populations is a critical component of WHO's eight-point framework adapted from the End TB Strategy to target pre-elimination and, ultimately, elimination in low incidence countries. OVERVIEW: Recognizing the importance of expanding the response to LTBI, in 2014 WHO developed Guidelines on the Management of Latent Tuberculosis Infection. The guidelines are primarily targeted at high-income or upper middle-income countries with an estimated TB incidence rate of less than 100 per 100 000 population, because they are most likely to benefit from it due to their current TB epidemiology and resource availability. The overall objective of the guidelines is to provide public health approach guidance on evidence-based practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. Specific objectives include identifying and prioritizing at-risk population groups for targeted intervention of LTBI testing and treatment, including defining an algorithm, and recommending specific treatment options. The guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management based on available resources, epidemiology of TB including intensity of transmission, the health-care delivery system of the country, and other national and local determinants. |
| idsa abstract submission: Antituberculosis Chemotherapy Peter R. Donald, Paul D. Van Helden, 2011 Tuberculosis (TB) remains one of the major infectious diseases of mankind although drugs for its treatment have been available for nearly 60 years. The standard short-course 6-month regimen used since about 1980 has helped to save millions of lives, but co-infection with HIV has had a devastating effect on the epidemic, and multidrug-resistant TB is a growing problem, particularly in communities with a high incidence of HIV. Following the declaration by the WHO in the early 1990s that TB was a 'global health emergency', interest in TB research and the development of new drugs has increased significantly. This volume reviews anti-TB chemotherapy with the emphasis on the actions and pharmacology of existing drugs and the development and evaluation of new agents. A close look is taken at new research regarding our existing drugs by some of the best-known specialists in the field, and historical aspects of these agents are reviewed from a modern perspective. The prospects for the introduction of new drugs and different approaches of how to assess them in adults and in children are discussed in detail. Several papers address the problems associated with drug resistance, its spread and diagnosis. Compiled by two editors from Cape Town, which has a particularly high incidence of TB and is a centre of tuberculosis research, this publication is an indispensable reference for anyone involved in the management of TB either as a researcher, clinician or administrator, and those working in drug development. |
| idsa abstract submission: The Journal of Infectious Diseases , 1995-10 |
| idsa abstract submission: Communicating COVID-19 Monique Lewis, Eliza Govender, Kate Holland, 2021-10-07 This book explores communication during the first year of the COVID-19 pandemic. Featuring the work of leading communication scholars from around the world, it offers insights and analyses into how individuals, organisations, communities, and nations have grappled with understanding and responding to the pandemic that has rocked the world. The book examines the role of journalists and news media in constructing meanings about the pandemic, with chapters focusing on public interest journalism, health workers and imagined audiences in COVID-19 news. It considers public health responses in different countries, with chapters examining community-driven approaches, communication strategies of governments and political leaders, public health advocacy, and pandemic inequalities. The role of digital media and technology is also unravelled, including social media sharing of misinformation and memetic humour, crowdsourcing initiatives, the use of data in modelling, tracking and tracing, and strategies for managing uncertainties created in a pandemic. |
| idsa abstract submission: Challenges in Infectious Diseases I.W. Fong, 2012-09-06 This next volume in the series will provide up to date Information and discussion on future approach to control several challenging Infectious Disease worldwide. The past decade has been highlighted by numerous advances in research of medical scientific knowledge. medical technology and the biological and diagnostic techniques-but somewhat less dramatic changes or improvement in management of medical conditions. This volume will address some of the emerging issues, challenges, and controversies in Infectious Diseases. |
| idsa abstract submission: Graphis , 1983 |
| idsa abstract submission: Antifungal Chemotherapy D. C. E. Speller, 1980 |
| idsa abstract submission: Management of Chronic Kidney Disease Mustafa Arıcı, 2024-12-13 The second edition of this essential work presents how to diagnose, treat and develop an appropriate management plan for patients with chronic kidney disease (CKD). Significantly updated chapters cover the fundamental sciences associated with CKD, its clinical assessment, evaluation, management of risk factors, along with cardiovascular disease in the context of CKD. Detailed insight is provided on how to assess for and manage a variety of CKD complications and special circumstances in CKD patients. The path to renal replacement therapy is also thoroughly described. New topics featured include associated rheumatic and electrolyte disorders. Furthermore, diagnostic and therapeutic approaches are presented according to the latest staging system for CKD, with patient care being discussed separately for each disease stage. The book also recognizes the needs of busy clinicians by including helpful boxes summarizing the evidence on diagnostic and therapeutic issues and practice pearls based upon the latest guidelines. Management of Chronic Kidney Disease: A Clinician's Guide is a comprehensive practically applicable guide to the management of patients with CKD. Its didactic features enable the reader to quickly identify the key points covered and disseminate the information they require, making it a valuable resource for all practicing and trainee medical practitioners who encounter these patients.. |
| idsa abstract submission: Performance Standards for Antimicrobial Susceptibility Testing Matthew A. Wikler, 2006 |
| idsa abstract submission: Guidelines for Diagnosing and Managing Disseminated Histoplasmosis Among People Living with HIV Pan American Pan American Health Organization, 2020-06-18 Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5-15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV. Although the burden of disease is concentrated in the Americas, the recommendations presented within these guidelines are applicable globally. These guidelines were produced in accordance with the World Health Organization (WHO) handbook for guideline development. The Guideline Development Group elaborated the final recommendations based on a systematic review of scientific literature and critical evaluation of the evidence available using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. These guidelines are intended for health-care providers, HIV program managers, policy-makers, national treatment advisory boards, researchers, and other professionals involved in caring for people who either have or may be at risk of developing disseminated histoplasmosis. |
| idsa abstract submission: Publication Manual of the American Psychological Association American Psychological Association, 2019-10 The Publication Manual of the American Psychological Association is the style manual of choice for writers, editors, students, and educators in the social and behavioral sciences, nursing, education, business, and related disciplines. |
| idsa abstract submission: Global Gidelines for the Pevention of Surgical Site Infection World Health Organization, 2017-01-27 Surgical site infections are caused by bacteria that get in through incisions made during surgery. They threaten the lives of millions of patients each year and contribute to the spread of antibiotic resistance. In low- and middle-income countries, 11% of patients who undergo surgery are infected in the process. In Africa, up to 20% of women who have a caesarean section contract a wound infection, compromising their own health and their ability to care for their babies. But surgical site infections are not just a problem for poor countries. In the United States, they contribute to patients spending more than 400 000 extra days in hospital at a cost of an additional US $10 billion per year. No international evidence-based guidelines had previously been available before WHO launched its global guidelines on the prevention of surgical site infection on 3 November 2016, and there are inconsistencies in the interpretation of evidence and recommendations in existing national guidelines. These new WHO guidelines are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences. |
| idsa abstract submission: CultureGrams , 2006 |
| idsa abstract submission: DNA Cloning David M. Glover, 1985 This volume presents for the first time in a single book a variety of current techniques for cloning and expressing DNA molecules. Protocols are described in sufficient detail for immediate use in the laboratory. |
| idsa abstract submission: Principles and Practice of Pediatric Infectious Diseases Sarah S. Long, Larry K. Pickering, Charles G. Prober, 2008 In print, online, or on your mobile device, Principles and Practice of Pediatric Infectious Disease provides the comprehensive and actionable coverage you need to understand, diagnose, and manage the ever-changing, high-risk clinical problems caused by infectious diseases in children and adolescents. With new chapters, expanded and updated coverage, and increased worldwide perspectives, this authoritative medical reference offers the latest need-to-know information in an easily-accessible, high-yield format for quick answers and fast, effective intervention!--Publisher's website. |
| idsa abstract submission: Pediatric Infectious Diseases: Essentials for Practice, 2nd Edition Samir S. Shah, Adam J. Ratner, Alex R. Kemper, 2018-11-06 Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The most practice-oriented guide to diagnosing and managing infectious diseases in children Pediatric Infectious Diseases: Essentials for Practice, Second Edition is filled with practical, clinically relevant guidance for successful infectious disease management. The care of the patient forms the core of this indispensable resource, which also provides perspectives on epidemiology, pathophysiology, and diagnosis that every pediatrician, pediatric hospitalist, and pediatric nurse practitioner needs to know. The book's high-yield coverage includes detailed, yet precise overviews of specific infections and their etiology, along with proven diagnostic and management strategies that readers can incorporate into their practice right away. FEATURES: • Tips that tell you what you must know--and do--at every stage of care • Diagnostic and treatment algorithms • Signs/Symptoms and Differential Diagnosis boxes • When to Refer boxes, which examine all the relevant clinical considerations • Diagnostic Tests--with a realistic emphasis on the right tests to order • Medical Treatment coverage that includes drugs, dosages, and administration in an easy-to-read tabular format • Convenient icons and a templated chapter design • Numerous clinical color photos and didactic diagrams • NEW! Clinical Pearls boxes accompany coverage of each infectious disease • Updated treatment guidelines and protocols from the CDC If you are in need of an up-to-date, clinically relevant guide to treating infectious diseases in pediatric patients, your search ends here. |
IDSA Home
With your IDSA membership, you get access to leading research, more professional development opportunities and access to the world’s largest network of leading infectious diseases experts.
Home - International Data Spaces
4 days ago · The International Data Spaces Association (IDSA) is a non-profit organization focusing on establishing and promoting standards for data spaces – trusted environments …
Practice guidelines - IDSA
IDSA Policy and Priorities. Access & Reimbursement; Antimicrobial Resistance; Diagnostics; Funding Policy; Global Health
IDSA Practice Guideline Highlights & Status
Listed below is a summary of 2022, 2023 and 2024 highlights for IDSA guidelines as well as guidelines endorsed by IDSA.
IDSA Guidelines on the Treatment and Management of Patients …
May 30, 2025 · IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about …
IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant …
Jul 12, 2024 · IDSA is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections.
About us - IDSA
For more than 60 years, IDSA has been a leading force in that progress — by bringing together ID professionals to discuss the pathogenesis of infectious diseases, the attributes of microbes, …
Membership - IDSA
The field of infectious diseases is constantly evolving — and so are the benefits of a membership with IDSA. From research to education, advocacy and representation, discover why 13,000 …
Industrial Designers Society of America - IDSA
IDSA’s professional gatherings advance the profession by bringing together some of the biggest names and brightest minds in industrial design and related fields.
MyIDSA - Infectious Disease Society of America
Given the rapidity of emerging literature, the Infectious Diseases Society of America (IDSA) identified the need to develop living, frequently updated evidence-based guidelines to support …
IDSA Home
With your IDSA membership, you get access to leading research, more professional development opportunities and access to the world’s largest network of leading infectious diseases experts.
Home - International Data Spaces
4 days ago · The International Data Spaces Association (IDSA) is a non-profit organization focusing on establishing and promoting standards for data spaces – trusted environments where …
Practice guidelines - IDSA
IDSA Policy and Priorities. Access & Reimbursement; Antimicrobial Resistance; Diagnostics; Funding Policy; Global Health
IDSA Practice Guideline Highlights & Status
Listed below is a summary of 2022, 2023 and 2024 highlights for IDSA guidelines as well as guidelines endorsed by IDSA.
IDSA Guidelines on the Treatment and Management of Patients …
May 30, 2025 · IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about …
IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant …
Jul 12, 2024 · IDSA is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections.
About us - IDSA
For more than 60 years, IDSA has been a leading force in that progress — by bringing together ID professionals to discuss the pathogenesis of infectious diseases, the attributes of microbes, …
Membership - IDSA
The field of infectious diseases is constantly evolving — and so are the benefits of a membership with IDSA. From research to education, advocacy and representation, discover why 13,000-plus …
Industrial Designers Society of America - IDSA
IDSA’s professional gatherings advance the profession by bringing together some of the biggest names and brightest minds in industrial design and related fields.
MyIDSA - Infectious Disease Society of America
Given the rapidity of emerging literature, the Infectious Diseases Society of America (IDSA) identified the need to develop living, frequently updated evidence-based guidelines to support …
